HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduced temporal lobe blood flow in Alzheimer's disease.

Abstract
We used single photon emission computed tomography with the blood flow tracer [123I]N-isopropyl-p-iodoamphetamine (IMP) to study regional cerebral blood flow (rCBF) in 50 mildly and moderately demented Alzheimer's disease (AD) patients to evaluate rCBF as a function of disease severity. Relative rCBF (normalized to occipital cortex) was significantly lower than controls in temporal cortex for both mildly and moderately demented patients. Similar numbers of patients in both groups demonstrated perfusion abnormalities in temporal neocortex. Parietal cortex was more variably involved with greater numbers of moderately than mildly demented patients showing perfusion abnormalities. Relative rCBF in dirsolateral frontal cortex was reduced only in the moderately demented patients. Disease severity, as measured by the Mini Mental Status Examination, was associated with relative rCBF only in dorsolateral frontal and parietal cortex. These results suggest that the temporal lobes are the first neocortical regions affected by AD and that other cortical areas become involved as the disease progresses.
AuthorsJ L Eberling, W J Jagust, B R Reed, M G Baker
JournalNeurobiology of aging (Neurobiol Aging) 1992 Jul-Aug Vol. 13 Issue 4 Pg. 483-91 ISSN: 0197-4580 [Print] United States
PMID1508299 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Aged
  • Alzheimer Disease (diagnostic imaging, physiopathology)
  • Cerebrovascular Circulation (physiology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Parietal Lobe (blood supply)
  • Temporal Lobe (blood supply, pathology)
  • Tomography, Emission-Computed, Single-Photon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: